Cogent Biosciences (COGT) Other financing activities (2018 - 2026)

Cogent Biosciences (COGT) has 8 years of Other financing activities data on file, last reported at $1.1 million in Q1 2026.

• On a quarterly basis, Other financing activities rose 680.88% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $2.3 million, a 579.4% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 578.39% from the prior year.
• Other financing activities for Q1 2026 stood at $1.1 million, up from -$214.4 million in the prior quarter.
• Over the last five years, Other financing activities for COGT reached as high as $215.2 million in Q3 2025 and fell as low as -$214.4 million in Q4 2025.
• Historically, Other financing activities has averaged $245437.5 across 5 years, with a median of $174500.0 in 2023.
• On a YoY basis, Other financing activities climbed as much as 117060.87% in 2025 and fell as far as 794329.63% in 2025.
• Year by year, Other financing activities stood at -$572000.0 in 2022, then jumped by 137.24% to $213000.0 in 2023, then tumbled by 87.32% to $27000.0 in 2024, then tumbled by 794329.63% to -$214.4 million in 2025, then surged by 100.5% to $1.1 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $1.1 million in Q1 2026, -$214.4 million in Q4 2025, and $215.2 million in Q3 2025.